ID
32010
Beskrivning
Study ID: 105548 Clinical Study ID: HZA105548 Study Title: A double-blind, randomized, placebo-controlled, repeat dose, 2-way crossover drug interaction study to investigate the pharmacokinetic and pharmacodynamic effects following administration of fluticasone furoate/GW642444M Inhalation Powder with ketoconazole Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01165125 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: fluticasone furoate/vilanterol; vilanterol Trade Name: Relvar; vilanterol Study Indication: Asthma
Nyckelord
Versioner (1)
- 2018-10-11 2018-10-11 -
Rättsinnehavare
GlaxoSmithKline
Uppladdad den
11 oktober 2018
DOI
För en begäran logga in.
Licens
Creative Commons BY-NC 3.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Pharmacokinetic and pharmacodynamic effects following administration of fluticasone Inhalation Powder with ketoconazole NCT01165125
Inform Screening, Enrolment, Date of visit, Demography
- StudyEvent: ODM
Beskrivning
Inform Enrolment
Alias
- UMLS CUI-1
- C1552002
- UMLS CUI-2
- C4041024
Beskrivning
Date of visit
Alias
- UMLS CUI-1
- C1320303
Beskrivning
Demography
Alias
- UMLS CUI-1
- C0011298
Beskrivning
Patient date of birth
Datatyp
date
Alias
- UMLS CUI [1]
- C0421451
Beskrivning
Gender
Datatyp
text
Alias
- UMLS CUI [1]
- C0079399
Beskrivning
Female of child bearing age
Datatyp
integer
Alias
- UMLS CUI [1]
- C1960468
Beskrivning
Ethnic group
Datatyp
integer
Alias
- UMLS CUI [1]
- C0015031
Beskrivning
Your ancestry or national origin
Datatyp
integer
Alias
- UMLS CUI [1]
- C3841890
Similar models
Inform Screening, Enrolment, Date of visit, Demography
- StudyEvent: ODM
C4041024 (UMLS CUI-2)
C2985720 (UMLS CUI [2])